129Xe Gas Exchange Imaging in IPF and cHP: A Reliability Study

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 1, 2022

Primary Completion Date

August 1, 2022

Study Completion Date

August 1, 2022

Conditions
Idiopathic Pulmonary FibrosisHypersensitivity Pneumonitis
Interventions
DRUG

Hyperpolarized Xe129

Whether magnetic resonance imaging (MRI) using inhaled hyper-polarized 129 Xenon gas can help visualize impaired lung function to assess patients with cHP and IPF.

Sponsors
All Listed Sponsors
collaborator

Duke University

OTHER

collaborator

Children's Hospital Medical Center, Cincinnati

OTHER

collaborator

Boehringer Ingelheim

INDUSTRY

lead

University of Kansas Medical Center

OTHER